Cost-Effectiveness of Cervical-Cancer Screening in Five Developing Countries
Top Cited Papers
- 17 November 2005
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 353 (20), 2158-2168
- https://doi.org/10.1056/nejmsa044278
Abstract
Cervical-cancer screening strategies that involve the use of conventional cytology and require multiple visits have been impractical in developing countries.Keywords
This publication has 16 references indexed in Scilit:
- Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trialThe Lancet, 2004
- Cervical cancerThe Lancet, 2003
- THE COST-EFFECTIVENESS OF PERMETHRIN-TREATED BED NETS IN AN AREA OF INTENSE MALARIA TRANSMISSION IN WESTERN KENYAThe American Journal of Tropical Medicine and Hygiene, 2003
- Programme costs in the economic evaluation of health interventionsCost Effectiveness and Resource Allocation, 2003
- A Controlled Trial of a Human Papillomavirus Type 16 VaccineNew England Journal of Medicine, 2002
- Feasibility and cost-effectiveness of standardised second-line drug treatment for chronic tuberculosis patients: a national cohort study in PeruThe Lancet, 2002
- Policy Analysis of Cervical Cancer Screening Strategies in Low-Resource SettingsJAMA, 2001
- Visual inspection with acetic acid for cervical-cancer screening: test qualities in a primary-care settingThe Lancet, 1999
- Visual inspection with acetic acid in the early detection of cervical cancer and precursorsInternational Journal of Cancer, 1999
- Care and costs for advanced cervical cancerEuropean Journal Of Cancer, 1992